Nuevocor: Funding, Investors & Team (Sep 2026)
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic treatments for genetic heart diseases that currently have no cure by utilizing information from our PrOSIA mechanobiology platform.
Nuevocor has raised $56.6M across 2 funding rounds on record, the most recent a Series B of $45.0M announced in May 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Nuevocor Company Profile and Key Stats
Latest funding round on record: May 2025.
Nuevocor Funding Rounds
Nuevocor raised $11.6M in an undisclosed round announced in Nov 2022.
2.5 years later, a Series B of $45.0M was announced in May 2025.
Nuevocor Founders and Leadership Team
No contact details are on record for this team yet.
Nuevocor Funding Compared to Other Biotechnology Startups
Nuevocor's latest round of $45.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Nuevocor in Biotechnology and Singapore
Companies Similar to Nuevocor
YouLabs is an early-stage, data-driven biotechnology and longevity technology company focused on shifting…
Volition is a worldwide life sciences organization creating straightforward, simple to utilize blood-based…
ImmunoScape is a company focused on immunomics, using a technology platform to analyze and characterize the…
Aevice Health Pte Ltd is a Singaporean company that originated from Nanyang Technological University and…
Mirxes is a biotech firm focused on uncovering, advancing, and providing precise preventive healthcare…
BioDefense introduces Bioshield, a product derived from edible ingredients designed to safeguard your food by…
Auristone delivers practical clinical insights through our epigenomics workflows, providing actionable…
ASLAN is a pharmaceutical company that develops novel medicines for global markets. It specializes in…
GDMC is a pharmaceutical organization that specializes in the production and development of genetic…
Meatiply, a company focused on food research, specializes in the creation and manufacturing of meat…
Empowering Healthier Meals by Harnessing the Best from Nature and Combining that our Knowledge of Food…
Automera dedicates itself to the creation of innovative therapeutic approaches for drug development.
Nuevocor Funding FAQs
What does Nuevocor do?
Nuevocor, which has locations in both the United States and Singapore, is working on creating genetic treatments for genetic heart diseases that currently have no cure by utilizing information from our PrOSIA mechanobiology platform.
How much funding has Nuevocor raised?
Nuevocor has raised $56.6M across 2 rounds on record. The most recent is a Series B of $45.0M announced in May 2025.
When did Nuevocor last raise funding?
Nuevocor's most recent funding round on record is a Series B of $45.0M, announced in May 2025.
Who founded Nuevocor?
FundedIQ lists Yann Chong Tan (Founder) at Nuevocor.
Where is Nuevocor headquartered?
Nuevocor is based in Singapore, Central Region, Singapore.
How many employees does Nuevocor have?
Nuevocor is in the 11-50 employee band.
How does Nuevocor's funding compare to other Biotechnology startups?
Nuevocor's latest round of $45.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Nuevocor Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Nuevocor is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.